Fact CheckerSign in

NCT07851818Not yet recruiting

Screening Psychosocial Distress in Head and Neck Cancer

Psychosocial Distress Screening in Patients Treated for Head and Neck Cancer : The Value of Screening in Speech-Language Therapy Practice

Source: ClinicalTrials.gov · Last updated 1 Oct 2026

Brief summary (registry, in English)

This prospective, multicenter study aims to assess the presence of psychosocial distress using the Distress Thermometer in patients treated for head and neck cancer at the initiation of their speech-language therapy. It also seeks to evaluate the evolution of this distress over a two-month period, as well as its correlation with patient engagement in therapy, functional disorders, and overall quality of life (assessed using the EORTC QLQ-C30 and QLQ-HN35 questionnaires). By capturing longitudinal changes in distress levels, functional impairments, and patient commitment to therapy, this research seeks to clarify the SLP's role in comprehensive supportive oncology care and optimize timely psychological referrals for vulnerable patients. The study hypothesizes that a significant proportion of patients experience clinically meaningful psychosocial distress (score ≥ 4 on the Distress Thermometer) at the start of speech-language therapy. It is also expected that this distress correlates with lower therapeutic engagement and impaired quality of life, and that early screening by speech-language pathologists will improve the timely referral of patients to psychological support professionals.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
21 Sept 2026
Start date
30 Nov 2026
Primary completion date
30 Nov 2027
Lead sponsor
Hôpital NOVO
NCT number
NCT07851818

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 30 Nov 2026 to the primary completion date, 30 Nov 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe cognitive impairment preventing the completion of the questionnaire
  • Clinical condition preventing participation
  • Severe, unstabilized psychiatric disorders

Other

  • Palliative care initiated

Who the study is looking for

  • Adult patients aged 18 years or older
  • Patients managed following a diagnosis of squamous cell carcinoma of the upper aerodigestive tract
  • Requiring speech-language pathology care
  • Initiation of curative-intent treatment dating back less than one month
  • Sufficient understanding of the French language to complete the study questionnaires
  • Patient who has been informed about the research and has not expressed any objection to participating

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.